Profound Medical (PROF) Total Current Liabilities (2018 - 2026)
Profound Medical's (PROF) quarterly Total Current Liabilities came in at $10.6 million in Q1 2026, up 100.32% year-on-year from $5.3 million in Q1 2025, and up 74.6% quarter-over-quarter from $6.1 million in Q4 2025.
Profound Medical (PROF) Total Current Liabilities (2018 - 2026) Analysis & Trends
Profound Medical's Total Current Liabilities history runs 9 years deep, the most recent figure standing at $10.6 million for Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 100.32% year-over-year to $10.6 million in Q1 2026; TTM through Mar 2026 was $10.6 million, a 100.32% increase from a year earlier, with the FY2025 full-year figure at $6.1 million, down 7.46% from the prior year.
- Total Current Liabilities improved to $10.6 million in Q1 2026 per PROF's latest filing, from $6.1 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $10.6 million in Q1 2026 and bottomed at $4.2 million in Q4 2022.
- The 5-year median for Total Current Liabilities is $6.2 million (2023), against an average of $6.8 million.
- Across the five-year window, Total Current Liabilities decreased 7.46% in 2025 and jumped 100.32% in 2026, its largest moves.
- Year by year, Total Current Liabilities stood at $4.2 million in 2022, then surged by 52.16% to $6.4 million in 2023, then gained by 3.09% to $6.6 million in 2024, then slipped by 7.46% to $6.1 million in 2025, then jumped by 74.6% to $10.6 million in 2026.
- Per Business Quant, the three latest PROF Total Current Liabilities figures stand at $10.6 million (Q1 2026), $6.1 million (Q4 2025), and $9.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Profound Medical | 248.64 Mn | 198.34 Mn | 3.83 Mn | 10.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.61 Mn |
| Dec 31, 2025 | 6.08 Mn |
| Sep 30, 2025 | 9.94 Mn |
| Jun 30, 2025 | 5.72 Mn |
| Mar 31, 2025 | 5.30 Mn |
| Dec 31, 2024 | 6.57 Mn |
| Dec 31, 2023 | 6.37 Mn |
| Dec 31, 2022 | 4.19 Mn |
| Dec 31, 2021 | 4.16 Mn |
| Dec 31, 2020 | 4.81 Mn |
| Dec 31, 2019 | 8.09 Mn |
| Jan 1, 2019 | 5.78 Mn |
| Dec 31, 2018 | 5.97 Mn |